Stay updated on SPL7013 Gel in BV Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T06:35:43.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH website updates and says content may use both “Super Intelligence” and “Artificial Intelligence” during a terminology transition.
    Difference
    1%
    Check dated 2026-10-25T06:48:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T05:25:59.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s displayed site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T07:59:57.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study results content with a standard access-denied message.
    Difference
    18%
    Check dated 2026-09-20T02:57:23.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 to reflect a new build. This is a metadata update and does not modify the visible content or functionality of the page.
    Difference
    0.0%
    Check dated 2026-08-30T00:27:34.000Z thumbnail image

Stay in the know with updates to SPL7013 Gel in BV Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.